Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Notch 4 receptor is a type I transmembrane protein and a member of the Notch family of receptors. It plays a critical role in cell fate decisions during development and in adult tissues. NOTCH4 acts as a receptor for membrane-bound ligands, triggering proteolytic cleavage and release of its intracellular domain to modulate gene expression in the nucleus. Dysregulation of NOTCH4 has been associated with susceptibility to schizophrenia, hematologic cancers, and solid tumors, including breast and pancreatic cancer.
Ligand binding to NOTCH4 triggers proteolytic cleavage and release of its intracellular domain, which translocates to the nucleus to modulate gene expression via the CBF1/RBPJκ complex.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Notch 4 Receptor (NOTCH4).